{"id":"F2018L01175","name":"Statement of Principles concerning sinusitis (Reasonable Hypothesis) (No. 73 of 2018)","slug":"statement-of-principles-concerning-sinusitis-reasonable-hypothesis-no-73-of-2018","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":439731,"registerId":"F2018L01175-fast-fetch-1775955641949","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning sinusitis (Reasonable Hypothesis) (No. 73 of 2018)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n![RMA-Red](image.001.jpeg)\n\n \n\nStatement of Principles\n\nconcerning\n\nSINUSITIS  (Reasonable Hypothesis)\n\n(No. 73 of 2018)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n \n\nDated                                           24 August 2018\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the  Repatriation Medical Authority  was affixed to this instrument  at the direction of:<br> |\n| --- |\n| <br>![](image.002.png)<br>Professor Nicholas Saunders AO<br>Chairperson<br> |\n\n\n \n\n   \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1               Name\n\nThis is the Statement of Principles concerning sinusitis (Reasonable Hypothesis) (No. 73 of 2018).\n\n2               Commencement\n\n              This instrument commences on 24 September 2018.\n\n3               Authority\n\nThis instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n4               Repeal\n\nThe Statement of Principles concerning sinusitis No. 9 of 2010 (Federal Register of Legislation No. F2010L00553) made under subsection 196B(2) of the VEA is repealed.\n\n5               Application\n\nThis instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6               Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7               Kind of injury, disease or death to which this Statement of Principles relates\n\n(1)          This Statement of Principles is about sinusitis and death from sinusitis.\n\nMeaning of sinusitis\n\n(2)          For the purposes of this Statement of Principles, sinusitis (also known as rhinosinusitis):\n\n(a)          means inflammation of the nasal cavity and the paranasal sinuses; and\n\n(b)          includes acute sinusitis and chronic sinusitis.\n\nNote: Sinusitis is characterised by the following signs and symptoms: nasal blockage or congestion, nasal discharge (anterior or postnasal drip), facial pain or pressure, or reduction or loss of smell, and fluid within the sinuses.\n\n(3)          While sinusitis attracts ICD‑10‑AM code J01 or J32, in applying this Statement of Principles the meaning of sinusitis is that given in subsection (2).\n\n(4)          For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.\n\nDeath from sinusitis\n\n(5)          For the purposes of this Statement of Principles, sinusitis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's sinusitis.\n\nNote: terminal event is defined in the Schedule 1 – Dictionary.\n\n8               Basis for determining the factors\n\nThe Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that sinusitis and death from sinusitis can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.\n\n9               Factors that must exist\n\nAt least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting sinusitis or death from sinusitis with the circumstances of a person's relevant service:\n\n(1)          having impaired drainage of the sinus at the time of the clinical onset of sinusitis;\n\nNote: impaired drainage of the sinus is defined in the Schedule 1 - Dictionary.               \n\n(2)          having a viral, bacterial or fungal respiratory tract infection at the time of the clinical onset of sinusitis;\n\n(3)          being in an immunocompromised state as specified at the time of the clinical onset of sinusitis;\n\nNote: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.             \n\n(4)          having a specified medical condition at the time of the clinical onset of sinusitis;\n\nNote: specified medical condition is defined in the Schedule 1 - Dictionary.\n\n(5)          undergoing a course of therapeutic radiation for cancer, where the nasal cavity and paranasal sinuses were in the field of radiation, before the clinical onset of sinusitis;\n\n(6)          smoking at least one pack-year of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of sinusitis, and:\n\n(a)          smoking commenced at least one year before the clinical onset of sinusitis; and\n\n(b)          where smoking has ceased, the clinical onset of sinusitis has occurred within three months of smoking cessation;\n\nNote: pack-year of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.             \n\n(7)           being exposed to second-hand smoke:\n\n(a)          for at least 1 000 hours before the clinical onset of sinusitis; and\n\n(b)          where the first exposure to second-hand smoke commenced at least one year before the clinical onset of sinusitis; and\n\n(c)          where the last exposure to second-hand smoke occurred within the three months before the clinical onset of sinusitis;\n\nNote: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary.             \n\n(8)          inhaling a drug or irritant substance which results in:\n\n(a)           acute nasal symptoms or signs within 48 hours of the inhalation; and\n\n(b)          scarring or erosion of the nasal or sinus mucosa;\n\nbefore the clinical onset of sinusitis;\n\nNote 1: Examples of drugs include cocaine, lidocaine, methylphenidate and narcotics.\n\nNote 2: Examples of irritant substances include gases (ammonia, chlorine, mustard, nitrogen dioxide, sulphur dioxide), powdered solids (aspirin, baking soda, levamisole, capsules, tablets, pills) and lewisite.\n\nNote 3: Examples of acute nasal symptoms or signs include rhinorrhoea, and the inflammation, oedema, ulceration or haemorrhage of the nasal mucosa.\n\n(9)          inhaling airborne dusts, smoke from fires, or fumes or vapours from fuel or a chemical agent within the 48 hours before the clinical onset of sinusitis;\n\n(10)      for sinusitis affecting the maxillary sinus only, having a specified dental condition affecting the tissues adjacent to the affected maxillary sinus at the time of the clinical onset of sinusitis;\n\nNote: specified dental condition is defined in the Schedule 1 - Dictionary.             \n\n(11)      having impaired drainage of the sinus at the time of the clinical worsening of sinusitis;\n\nNote: impaired drainage of the sinus is defined in the Schedule 1 - Dictionary.               \n\n(12)      having a viral, bacterial or fungal respiratory tract infection at the time of the clinical worsening of sinusitis;\n\n(13)      being in an immunocompromised state as specified at the time of the clinical worsening of sinusitis;\n\nNote: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.             \n\n(14)      having a specified medical condition at the time of the clinical worsening of sinusitis;\n\nNote: specified medical condition is defined in the Schedule 1 - Dictionary.\n\n(15)      undergoing a course of therapeutic radiation for cancer, where the nasal cavity and paranasal sinuses were in the field of radiation, before the clinical worsening of sinusitis;\n\n(16)      smoking at least one pack-year of cigarettes, or the equivalent thereof in other tobacco products, before the clinical worsening of sinusitis, and:\n\n(a)          smoking commenced at least one year before the clinical worsening of sinusitis; and\n\n(b)          where smoking has ceased, the clinical worsening of sinusitis has occurred within three months of smoking cessation;\n\nNote: pack-year of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.             \n\n(17)       being exposed to second-hand smoke:\n\n(a)          for at least 1 000 hours before the clinical worsening of sinusitis; and\n\n(b)          where the first exposure to second-hand smoke commenced at least one year before the clinical worsening of sinusitis; and\n\n(c)          where the last exposure to second-hand smoke occurred within the three months before the clinical worsening of sinusitis;\n\nNote: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary.             \n\n(18)      inhaling a drug or irritant substance which results in:\n\n(a)           acute nasal symptoms or signs within 48 hours of the inhalation; and\n\n(b)          scarring or erosion of the nasal or sinus mucosa;\n\nbefore the clinical worsening of sinusitis;\n\nNote 1: Examples of drugs include cocaine, lidocaine, methylphenidate and narcotics.\n\nNote 2: Examples of irritant substances include gases (ammonia, chlorine, mustard, nitrogen dioxide, sulphur dioxide), powdered solids (aspirin, baking soda, levamisole, capsules, tablets, pills) and lewisite.\n\nNote 3: Examples of acute nasal symptoms or signs include rhinorrhoea, and the inflammation, oedema, ulceration or haemorrhage of the nasal mucosa.\n\n(19)      inhaling airborne dusts, smoke from fires, or fumes or vapours from fuel or a chemical agent within the 48 hours before the clinical worsening of sinusitis;\n\n(20)      for sinusitis affecting the maxillary sinus only, having a specified dental condition affecting the tissues adjacent to the affected maxillary sinus at the time of the clinical worsening of sinusitis;\n\nNote: specified dental condition is defined in the Schedule 1 - Dictionary.             \n\n(21)      for sinusitis with nasal polyps only, using a drug belonging to the nonselective (COX-1 and COX-2 inhibitors) nonsteroidal anti-inflammatory class of drugs, at the time of the clinical worsening of sinusitis;\n\nNote: Nonselective (COX-1 and COX-2 inhibitors) nonsteroidal anti-inflammatory class of drugs:\n\n(a) includes drugs such as aspirin, diclofenac, ibuprofen, indomethacin, ketoprofen, ketorolac, mefanamic acid, paracetamol, piroxicam and sulindac; and\n\n(b) excludes drugs such as celecoxib, etoricoxib, meloxicam and parecoxib.\n\n(22)      inability to obtain appropriate clinical management for sinusitis.\n\n10           Relationship to service\n\n(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2)          The factors set out in subsections 9(11) to 9(22) apply only to material contribution to, or aggravation of, sinusitis where the person's sinusitis was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11           Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1)          if a factor referred to in section 9 applies in relation to a person; and\n\n(2)          that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary  \n\nNote:               See Section 6\n\n1               Definitions\n\nIn this instrument:\n\n                               being exposed to second-hand smoke means being in an enclosed space and inhaling smoke from burning tobacco products or smoke that has been exhaled by a person who is smoking.\n\n                               chronic renal failure means:\n\n(a)          having a glomerular filtration rate of less than 15 mL/min/1.73 m2 for a period of at least three months; or\n\n(b)          a need for renal replacement therapy (dialysis or transplantation) for treatment of complications of decreased glomerular filtration rate which would otherwise increase the risk of morbidity and mortality; or\n\n(c)          undergoing chronic dialysis.\n\n                               immunocompromised state as specified means a condition of substantially lowered immune function, such as would occur in the following conditions or circumstances:\n\n(a)          being treated with an immunosuppressive drug;\n\n(b)          having a haematological or solid organ malignancy;\n\n(c)          having chronic renal failure;\n\n(d)          having infection with human immunodeficiency virus;\n\n(e)          having severe malnutrition; or\n\n(f)           undergoing solid organ, stem cell or bone marrow transplantation.\n\nNote: chronic renal failure and immunosuppressive drug are also defined in the Schedule 1 - Dictionary.\n\n                               immunosuppressive drug means a drug or an agent which results in substantial suppression of immune responses.\n\nNote: Examples of an immunosuppressive drug include corticosteroids other than inhaled or topical corticosteroids, drugs used to prevent transplant rejection, tumour necrosis factor-α inhibitors and chemotherapeutic agents used for the treatment of cancer.\n\n                               impaired drainage of the sinus means one of the following which leads to a narrowing or obstruction of the affected sinus or sinus opening:\n\n(a)          an anatomical deformity including deviated septum, enlarged turbinates, adenoidal hypertrophy, fracture of the facial bones and any other bony structural abnormalities;\n\n(b)          a soft tissue abnormality or mucosal swelling affecting the sinus including polyps, tumours, inflammation, sarcoidosis, granulomas and scarring; or\n\n(c)          a foreign body including fungal balls, nasal packing, nasogastric or nasotracheal tubes, and dental detritus.\n\n                                MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n                               pack-year of cigarettes, or the equivalent thereof in other tobacco products means a calculation of consumption where one pack-year of cigarettes equals 20 tailor-made cigarettes per day for a period of one calendar year, or 7 300 cigarettes.  One tailor-made cigarette approximates one gram of tobacco or one gram of cigar or pipe tobacco by weight.  One pack-year of tailor-made cigarettes equates to 7.3 kilograms of smoking tobacco by weight.  Tobacco products mean cigarettes, pipe tobacco or cigars, smoked alone or in any combination.\n\n                               relevant service means:\n\n(a)          operational service under the VEA;\n\n(b)          peacekeeping service under the VEA;\n\n(c)          hazardous service under the VEA;\n\n(d)          British nuclear test defence service under the VEA;\n\n(e)          warlike service under the MRCA; or\n\n(f)           non-warlike service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n                               sinusitis—see subsection 7(2).\n\n                               specified dental condition means one of the following:\n\n(a)          displaced tooth or tooth fragments;\n\n(b)          endosseous implants;\n\n(c)          infected dental (apical or dentigerous) cyst;\n\n(d)          maxillary trauma;\n\n(e)          non-vital tooth;\n\n(f)           oro-antral fistula;\n\n(g)          periapical abscess;\n\n(h)          periapical granuloma; or\n\n(i)            periodontitis.\n\n                               specified medical condition means one of the following:\n\n(a)          allergic rhinitis;\n\n(b)          asthma;\n\n(c)          diabetes mellitus;\n\n(d)          gastro-oesophageal reflux disease; or\n\n(e)          sinus barotrauma.\n\n                               terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a)           pneumonia;\n\n(b)           respiratory failure;\n\n(c)           cardiac arrest;\n\n(d)           circulatory failure; or\n\n(e)           cessation of brain function.\n\n                               VEA means the Veterans' Entitlements Act 1986.\n\n \n\n \n","sortOrder":0}],"analysis":{"flash_summary":{"complexity_score":4,"scope_assessment":{"changed":true,"description":"This instrument repeals the 2010 Statement (section 4) and replaces it with a revised list of qualifying factors and clearer definitions (section 9; Schedule 1). It retains application to VEA s120A and MRCA s338 claims (section 5) but adds or clarifies practical thresholds (e.g. 48‑hour exposures, 1,000 hours second‑hand smoke, pack‑year rules), a nasal‑polyp/NSAID provision (9(21)) and inability to obtain appropriate clinical management (9(22)), thereby altering the practical scope of compensable claims."},"complexity_factors":["Technical medical criteria and definitions (sinusitis, impaired drainage, immunocompromised state) — Schedule 1; subsections 7(2), 9","Numerous specific exposure and temporal thresholds (e.g. 48 hours, 1,000 hours, 3‑month cessation) — subsections 9(8), 9(9), 9(6), 9(7)","Interaction with other Statements of Principles for overlapping injuries/diseases — section 11","Scope limited to particular claim pathways (VEA s120A, MRCA s338) and repeal of prior SOP — sections 4 and 5","Multiple discrete qualifying paths (at least one factor from a long list) rather than a single test — section 9","Detailed definitions of tobacco exposure and pack‑year calculation affecting proof and evidentiary burden — Schedule 1"],"plain_english_summary":"This Statement of Principles sets out the medical criteria the Repatriation Medical Authority will use to decide if sinusitis (including death contributed by sinusitis) can be connected to a person’s relevant military service for veteran or service‑member compensation claims. It affects veterans and members claiming under the VEA or MRCA by listing specific clinical factors, exposure and timing rules, and defined medical conditions that must exist to raise a reasonable hypothesis linking the condition to service."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":5,"scope_assessment":{"changed":false,"description":"This instrument maintains the established scope of Repatriation Medical Authority Statements of Principles. It replaces the 2010 version concerning the same condition (sinusitis) and operates within the same statutory framework (subsection 196B(2) of the VEA). The structure—defining the condition, listing specific causal/aggravation factors, and providing a dictionary—follows the standard template for RMA instruments. While the specific medical factors have been updated based on current evidence, the legislative scope remains confined to determining service connection for this specific disease."},"complexity_factors":["22 distinct factors with multiple sub-conditions and temporal requirements (e.g., 'within 48 hours', 'at least one year before', 'within three months of cessation')","11 defined terms in Schedule 1, several of which contain nested definitions (e.g., 'immunocompromised state as specified' references 'chronic renal failure' and 'immunosuppressive drug', which are also defined)","Parallel structure for onset vs. worsening factors (subsections 9(1)-10 mirror 9(11)-20), creating duplication that must be read carefully to distinguish application","Specific quantitative thresholds (e.g., '1,000 hours' of second-hand smoke exposure, 'one pack-year' of cigarettes, '7,300 cigarettes' equivalent)","Cross-reference to other Statements of Principles in section 11, requiring readers to consult potentially multiple instruments","Medical and technical terminology requiring specialist knowledge (e.g., 'endosseous implants', 'oro-antral fistula', 'sinus barotrauma', 'ICD-10-AM codes')","Conditional logic in section 10(2) restricting factors 9(11)-9(22) to aggravation cases only, not initial onset during service"],"plain_english_summary":"The Repatriation Medical Authority’s Statement of Principles lists 22 medical factors that, if present, create a “reasonable hypothesis” that a veteran’s sinusitis was caused or aggravated by military service (covering both new onset and clinical worsening). It applies to veterans, peacekeepers and current/former Defence members claiming under the Veterans’ Entitlements Act 1986 or the Military Rehabilitation and Compensation Act 2004 and is the key gateway to compensation, replacing the 2010 version."}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-sinusitis-reasonable-hypothesis-no-73-of-2018","history":"/api/acts/statement-of-principles-concerning-sinusitis-reasonable-hypothesis-no-73-of-2018/history","analysis":"/api/acts/statement-of-principles-concerning-sinusitis-reasonable-hypothesis-no-73-of-2018/analysis","conflicts":"/api/acts/statement-of-principles-concerning-sinusitis-reasonable-hypothesis-no-73-of-2018/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-sinusitis-reasonable-hypothesis-no-73-of-2018/important-cases","documents":"/api/acts/statement-of-principles-concerning-sinusitis-reasonable-hypothesis-no-73-of-2018/documents"}}